Amyloid-targeting therapies such as lecanemab and donanemab require careful patient selection and safety monitoring in early symptomatic Alzheimer s disease. In this activity, Alzheimer s specialist Dani Cabral, MD, discusses a practical approach to identifying potential treatment candidates, confirming amyloid pathology, and interpreting amyloid PET, cerebrospinal fluid, and blood-based biomarkers in clinical context. She examines factors associated with amyloid-related imaging abnormality (ARIA) risk, including APOE 4 status, baseline MRI findings, and concomitant medications such as anticoagulants. The activity also highlights agent-specific MRI monitoring, symptom surveillance, and coordinated practice workflows to support ARIA detection and management and informed treatment discussions with patients and care partners.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
CME included with membership
| Free Registration | Free |
| Tufts-Affiliated HCP - Early Bird (by 10/5/26) | $75 |
| Tufts-Affiliated HCP - Standard | $175 |
| Trainees & Allied Health - Early Bird (by 10/5/26) | $75 |
| Trainees & Allied Health - Standard | $175 |
| Physicians - Early Bird (by 10/5/26) | $150 |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Neurology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedOct 7, 2026
-
Last day to claim creditOct 8, 2027 12 months left
-
Global Learning Collaborative Reimagining Alzheimer’s Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy an Impact Live Series
-
Global Learning Collaborative When Mild Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer s Disease
-
Global Learning Collaborative Reimagining Alzheimer’s Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
